grocery glp-1 news How weight loss drugs are changing the store Grocery shopping shifts as GLP

But researchers have found that they may also be effective in treating conditions like kidney disease, peripheral neuropathy, polycystic ovarian syndrome, liver disease, and even neurodegenerative diseases like Parkinsons and Alzheimers disease

The mechanism of action involves several physiological effects: GLP-1 receptor agonists stimulate insulin secretion in a glucose-dependent manner, suppress glucagon release, slow gastric emptying, and reduce appetite through central nervous system pathways

De sleutel ligt in het aanpakken van die dagelijkse gewoontes: slaaptekort dat hongerhormonen activeert, emotie-eten als reactie op stress, structureel te weinig beweging, onregelmatige eetmomenten

5, 6 Furthermore, non-clinical and clinical studies have demonstrated increased satiety, reduced food intake and subsequent reductions in body weight following administration of GLP-1, 7, 8 leading to investigations into its potential for the treatment of obesity

Two of the most talked-about options are Wegovy (semaglutide) and Zepbound (Tirzepatide)

While these medications play a role in metabolic care, they also introduce significant clinical considerations, particularly for individuals with current or past eating disorders